vs
Side-by-side financial comparison of Community West Bancshares (CWBC) and IRONWOOD PHARMACEUTICALS INC (IRWD). Click either name above to swap in a different company.
IRONWOOD PHARMACEUTICALS INC is the larger business by last-quarter revenue ($47.7M vs $38.3M, roughly 1.2× Community West Bancshares). On growth, Community West Bancshares posted the faster year-over-year revenue change (11.6% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $43.6M). Over the past eight quarters, Community West Bancshares's revenue compounded faster (36.0% CAGR vs -20.2%).
Community West BancsharesCWBCEarnings & Financial Report
Community West Bancshares is a registered bank holding company headquartered in California. It wholly owns Community West Bank under the Bank Holding Company Act.
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
CWBC vs IRWD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $38.3M | $47.7M |
| Net Profit | — | $-2.3M |
| Gross Margin | — | — |
| Operating Margin | 40.0% | 14.3% |
| Net Margin | — | -4.8% |
| Revenue YoY | 11.6% | -47.3% |
| Net Profit YoY | — | -200.9% |
| EPS (diluted) | $0.58 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $38.3M | $47.7M | ||
| Q3 25 | $37.9M | $122.1M | ||
| Q2 25 | $35.7M | $85.2M | ||
| Q1 25 | $34.8M | $41.1M | ||
| Q4 24 | $34.3M | $90.5M | ||
| Q3 24 | $31.3M | $91.6M | ||
| Q2 24 | $30.5M | $94.4M | ||
| Q1 24 | $20.7M | $74.9M |
| Q4 25 | — | $-2.3M | ||
| Q3 25 | $10.9M | $40.1M | ||
| Q2 25 | $7.8M | $23.6M | ||
| Q1 25 | $8.3M | $-37.4M | ||
| Q4 24 | — | $2.3M | ||
| Q3 24 | $3.4M | $3.6M | ||
| Q2 24 | $-6.3M | $-860.0K | ||
| Q1 24 | $3.7M | $-4.2M |
| Q4 25 | 40.0% | 14.3% | ||
| Q3 25 | 39.8% | 61.8% | ||
| Q2 25 | 30.2% | 53.2% | ||
| Q1 25 | 32.7% | -70.7% | ||
| Q4 24 | 31.0% | 34.8% | ||
| Q3 24 | 13.3% | 28.0% | ||
| Q2 24 | -25.9% | 26.5% | ||
| Q1 24 | 23.2% | 14.7% |
| Q4 25 | — | -4.8% | ||
| Q3 25 | 28.7% | 32.8% | ||
| Q2 25 | 22.0% | 27.7% | ||
| Q1 25 | 23.8% | -90.9% | ||
| Q4 24 | — | 2.5% | ||
| Q3 24 | 10.8% | 4.0% | ||
| Q2 24 | -20.7% | -0.9% | ||
| Q1 24 | 17.8% | -5.6% |
| Q4 25 | $0.58 | $0.01 | ||
| Q3 25 | $0.57 | $0.23 | ||
| Q2 25 | $0.41 | $0.14 | ||
| Q1 25 | $0.44 | $-0.23 | ||
| Q4 24 | $0.29 | $0.03 | ||
| Q3 24 | $0.18 | $0.02 | ||
| Q2 24 | $-0.33 | $-0.01 | ||
| Q1 24 | $0.31 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $119.0M | $215.5M |
| Total DebtLower is stronger | $69.5M | — |
| Stockholders' EquityBook value | $409.6M | $-261.8M |
| Total Assets | $3.7B | $396.9M |
| Debt / EquityLower = less leverage | 0.17× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $119.0M | $215.5M | ||
| Q3 25 | $121.6M | $140.4M | ||
| Q2 25 | $134.4M | $92.9M | ||
| Q1 25 | $148.4M | $108.5M | ||
| Q4 24 | $120.4M | $88.6M | ||
| Q3 24 | $149.0M | $88.2M | ||
| Q2 24 | $109.7M | $105.5M | ||
| Q1 24 | $61.0M | $121.5M |
| Q4 25 | $69.5M | — | ||
| Q3 25 | — | $199.5M | ||
| Q2 25 | — | $199.3M | ||
| Q1 25 | — | $199.2M | ||
| Q4 24 | $69.9M | $199.0M | ||
| Q3 24 | — | $198.8M | ||
| Q2 24 | — | $198.6M | ||
| Q1 24 | — | $398.3M |
| Q4 25 | $409.6M | $-261.8M | ||
| Q3 25 | $397.6M | $-264.2M | ||
| Q2 25 | $380.0M | $-308.2M | ||
| Q1 25 | $372.2M | $-334.1M | ||
| Q4 24 | $362.7M | $-301.3M | ||
| Q3 24 | $363.5M | $-311.3M | ||
| Q2 24 | $350.2M | $-321.7M | ||
| Q1 24 | $211.7M | $-330.5M |
| Q4 25 | $3.7B | $396.9M | ||
| Q3 25 | $3.6B | $396.1M | ||
| Q2 25 | $3.6B | $342.9M | ||
| Q1 25 | $3.6B | $327.2M | ||
| Q4 24 | $3.5B | $350.9M | ||
| Q3 24 | $3.5B | $389.5M | ||
| Q2 24 | $3.5B | $395.6M | ||
| Q1 24 | $2.4B | $438.8M |
| Q4 25 | 0.17× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.19× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $46.1M | $74.6M |
| Free Cash FlowOCF − Capex | $43.6M | $74.6M |
| FCF MarginFCF / Revenue | 113.9% | 156.3% |
| Capex IntensityCapex / Revenue | 6.6% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $77.7M | $127.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $46.1M | $74.6M | ||
| Q3 25 | $13.2M | $47.6M | ||
| Q2 25 | $11.5M | $-15.1M | ||
| Q1 25 | $11.1M | $20.0M | ||
| Q4 24 | $22.2M | $15.2M | ||
| Q3 24 | $7.8M | $9.9M | ||
| Q2 24 | $5.2M | $33.5M | ||
| Q1 24 | $4.0M | $45.0M |
| Q4 25 | $43.6M | $74.6M | ||
| Q3 25 | $12.8M | $47.6M | ||
| Q2 25 | $10.6M | $-15.1M | ||
| Q1 25 | $10.8M | $19.9M | ||
| Q4 24 | $17.2M | — | ||
| Q3 24 | $5.2M | $9.9M | ||
| Q2 24 | $4.8M | $33.4M | ||
| Q1 24 | $3.6M | $44.9M |
| Q4 25 | 113.9% | 156.3% | ||
| Q3 25 | 33.7% | 39.0% | ||
| Q2 25 | 29.6% | -17.7% | ||
| Q1 25 | 30.9% | 48.4% | ||
| Q4 24 | 50.0% | — | ||
| Q3 24 | 16.7% | 10.8% | ||
| Q2 24 | 15.7% | 35.4% | ||
| Q1 24 | 17.3% | 60.0% |
| Q4 25 | 6.6% | 0.0% | ||
| Q3 25 | 1.1% | 0.0% | ||
| Q2 25 | 2.7% | 0.0% | ||
| Q1 25 | 0.9% | 0.1% | ||
| Q4 24 | 14.7% | 0.0% | ||
| Q3 24 | 8.1% | 0.0% | ||
| Q2 24 | 1.4% | 0.1% | ||
| Q1 24 | 2.1% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | 1.21× | 1.19× | ||
| Q2 25 | 1.47× | -0.64× | ||
| Q1 25 | 1.33× | — | ||
| Q4 24 | — | 6.74× | ||
| Q3 24 | 2.29× | 2.71× | ||
| Q2 24 | — | — | ||
| Q1 24 | 1.09× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
